(Q35490675)

8 August 2017

1 reference

title

Measures of survival benefit in cancer drug development and their limitations (English)

1 reference

8 August 2017

Ruth Etzioni

1

1 reference

8 August 2017

Roman Gulati

series ordinal

2

1 reference

8 August 2017

Daniel W Lin

series ordinal

3

1 reference

8 August 2017

publication date

1 March 2015

1 reference

8 August 2017

1 reference

8 August 2017

volume

33

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

122-127

1 reference

Enzalutamide in metastatic prostate cancer before chemotherapy

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Radical prostatectomy or watchful waiting in early prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Radical prostatectomy versus observation for localized prostate cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Prostate-cancer mortality at 11 years of follow-up

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

The use and interpretation of competing risks regression models

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Choice and interpretation of statistical tests used when competing risks are present

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Cumulative incidence in competing risks data and competing risks regression analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

Progression-free survival: meaningful or simply measurable?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4403641

The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinical

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2014.11.002

10.1016/J.UROLONC.2014.11.002

7 January 2021

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference